NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/17/2025
Back to search
Official data from USPTO
ET HEALTHCARE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ET HEALTHCARE
ST13
US500000088907220Class
1, 5, 9, 10
Filing
88907220
Registration
7836259
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
51
Latest update
06/17/2025
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
05/08/2020
Registration date
06/17/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/17/2025
Last transaction
06/17/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
2014-06-00
First use in commerce
2014-06-00
Drawing code
4
Owner type
03
Owner location
Palo Alto, CA, KY
Examiner
BURDECKI, ANNA C
Law office
L80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. S. (pessoa física)
Representatives
Andrew T. Pettit PERKINS COIE LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Reagents for reacting with biomolecules for scientific use; reagents for scientific use; reagents for reacting with biomolecules for research use; reagents for research use; diagnostic reagents for scientific research use; diagnostic reagentsbufferspreparationsexcept for medical and veterinary use; biochemical reagents used for non-medical purposes for detecting and/or analyzing antigensantibodiesproteinsligandsnucleotides; laboratory chemicalsantibody reagents used for the detection of antigens or antibodies in liquidcelltissue analysis for in vitro diagnostic use; diagnostic preparations other than for medical or veterinary purposesreagentsbufferspreparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations other than for medical or veterinary purposesreagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes
Class 5
Diagnostic reagents for medical use; diagnostic preparations for medical or veterinary purposesreagentsbufferspreparations for altering the nature of a probe to which biomolecules bind over the course of a diagnostic procedure; diagnostic preparations for medical or veterinary purposesreagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes reagentsbufferspreparations for modifying a probe to which biomolecules bind for diagnostic purposes
Class 9
Optical instruments for measuring a reaction by monitoring changes in the reflection of lightinterferometers; laboratory instruments in the nature of interferometers for use in collecting real-time measurements to support the analysis of biological molecules at different stages of therapeutic development; probes for scientificresearchdiagnostic purposesnot for medical or veterinary purposes; probes for scientific purposesprobes to which biomolecules bind over the course of a scientificresearchdiagnostic procedure; interferometric sensors; probes for scientific purposesprobes to which biomolecules bind during a scientificresearchdiagnostic procedure; probes for label-free analysis of assays being probes for scientific purposes; regenerable probes for scientific purposeprobes for use in multiple scientificresearchdiagnostic procedures; downloadable computer software for scientificresearchdiagnostic analysis of interferometric measurements; downloadable computer software for scientificresearchdiagnostic analysisfor performing antibody titer determination and isotyping; laboratory apparatusimmunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; laboratory apparatusautomated immunoassay analyzers for scientificresearchdiagnostic usenot for medical purposes
Class 10
Medical instrumentsdiagnostic instruments for the analysis of body fluids through the measuring of light interference; medical diagnostic instruments for the analysis of body fluids through interferometry; medical diagnostic instruments for the analysis of biomolecules through interferometry; medical diagnostic tool in the nature of medical instruments for analyzing body fluids for investigating scientific questions and conducting tests; interferometers for medical use; interferometric sensors for medical use; probes for detecting and/or analyzing molecules in protein or nucleotide arrays for medical purposes; probes to which biomolecules bind during a medical procedure; probes for medical purposes for label-free analysis of assays; regenerable probes for use in multiple medical procedures; diagnostic kits consisting primarily of antibodies and reagents for use in disease testing for medical purposes; medical diagnostic apparatusimmunoassay analyzers for measuring presence and/or concentration of biomolecules in a sample; medical diagnostic apparatusautomated immunoassay analyzers for medical use
Publications
History of USPTO decisions and trademark events.
51 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
06/17/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/27/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/27/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
04/23/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
04/22/2025
EX4G
SOU EXTENSION 4 GRANTED
04/22/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
04/17/2025
IUAF
USE AMENDMENT FILED
01/09/2025
EXT4
SOU EXTENSION 4 FILED
01/09/2025
EEXT
SOU TEAS EXTENSION RECEIVED
01/09/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/09/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/03/2024
EX3G
SOU EXTENSION 3 GRANTED
07/03/2024
EXT3
SOU EXTENSION 3 FILED
07/03/2024
EEXT
SOU TEAS EXTENSION RECEIVED
07/03/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/12/2024
EX2G
SOU EXTENSION 2 GRANTED
01/10/2024
EXT2
SOU EXTENSION 2 FILED
01/10/2024
EEXT
SOU TEAS EXTENSION RECEIVED
01/10/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/12/2023
EX1G
SOU EXTENSION 1 GRANTED
07/10/2023
EXT1
SOU EXTENSION 1 FILED
07/10/2023
EEXT
SOU TEAS EXTENSION RECEIVED
07/10/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
01/10/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/15/2022
PUBO
PUBLISHED FOR OPPOSITION
11/15/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/26/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/13/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/11/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/11/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/23/2022
GNFR
FINAL REFUSAL E-MAILED
08/23/2022
CNFR
FINAL REFUSAL WRITTEN
08/23/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/29/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
06/10/2022
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/13/2022
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
09/27/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/05/2021
GNSL
LETTER OF SUSPENSION E-MAILED
03/05/2021
CNSL
SUSPENSION LETTER WRITTEN
03/05/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/10/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/09/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/09/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/10/2020
GNRT
NON-FINAL ACTION E-MAILED
08/10/2020
CNRT
NON-FINAL ACTION WRITTEN
08/10/2020
DOCK
ASSIGNED TO EXAMINER
08/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/20/2020
NWAP
NEW APPLICATION ENTERED
05/12/2020
Continuous trademark protection
Get notified about every new filing that threatens ET HEALTHCARE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.